A Study to Collect the Somatuline® Injector Device Preferences of Patients Living With Neuroendocrine Tumor (NET) and Nurses Involved in the Care of Patients With NET

Clinical trial NCT05922579 · TERMINATED

Trial details

NCT number: NCT05922579
Sponsor: Ipsen
Status: TERMINATED
Study type: OBSERVATIONAL

Neuroendocrine Tumors

Start date: 2023-06-15
Primary completion: 2023-12-01
Enrollment: 191

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.